Abbott reaches agreement with Department of Justice to resolve claims relating to 2022 infant formula recall
Abbott has agreed to pay $385 million to resolve claims by the U.S. Department of Justice, certain relators, and the Attorneys General of several states relating to manufacturing and the 2022 recall of powdered infant formula at its Sturgis, Michigan facility. The settlement does not represent any finding of fault or liability, and the government has closed its criminal investigation into the matter. Abbott emphasized that no unopened, distributed infant formula has ever tested positive for Cronobacter sakazakii, citing FDA testing and a CDC conclusion of no definitive link between the Sturgis facility and the clinical cases behind the recall.
Key figures
- Recall year
- 2022
- Recall facility
- Sturgis, Michigan
- Settlement amount usd
- 385000000
- Criminal investigation closed
- Yes
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.